Denosumab prevented periprosthetic bone resorption better than risedronate after total hip arthroplasty

ConclusionDenosumab is more effective in preventing periprosthetic bone resorption than risedronate in the proximal femur. It also increased BMD around the stem implant following THA.

http://link.springer.com/10.1007/s00774-023-01405-2

Source: Journal of Bone and Mineral Metabolism - February 6, 2023 Category: Orthopaedics Source Type: research